A detailed history of Western Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Western Wealth Management, LLC holds 20,797 shares of ABBV stock, worth $4.17 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
20,797
Previous 20,258 2.66%
Holding current value
$4.17 Million
Previous $3.69 Million 3.28%
% of portfolio
0.27%
Previous 0.29%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$154.79 - $180.76 $83,431 - $97,429
539 Added 2.66%
20,797 $3.57 Million
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $2.41 Million - $2.74 Million
-15,061 Reduced 42.64%
20,258 $3.69 Million
Q4 2023

Jan 31, 2024

SELL
$137.6 - $154.97 $275,475 - $310,249
-2,002 Reduced 5.36%
35,319 $5.47 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $143,609 - $166,248
1,075 Added 2.97%
37,321 $5.56 Million
Q2 2023

Aug 30, 2023

SELL
$132.51 - $164.9 $226,062 - $281,319
-1,706 Reduced 4.5%
36,246 $4.88 Million
Q1 2023

Aug 30, 2023

BUY
$144.61 - $166.54 $652,046 - $750,928
4,509 Added 13.48%
37,952 $6.05 Million
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $3.02 Million - $3.62 Million
-21,821 Reduced 39.49%
33,443 $5.41 Million
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $33,015 - $37,866
-246 Reduced 0.44%
55,264 $7.6 Million
Q2 2022

Jul 18, 2022

SELL
$137.62 - $174.96 $154,684 - $196,655
-1,124 Reduced 1.98%
55,510 $8.5 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $4.43 Million - $5.5 Million
33,597 Added 145.84%
56,634 $9.18 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $659,083 - $833,930
-6,135 Reduced 21.03%
23,037 $3.12 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $1.18 Million - $1.32 Million
11,255 Added 62.82%
29,172 $3.29 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $68,745 - $75,680
672 Added 3.9%
17,917 $1.94 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $28,895 - $39,012
-359 Reduced 2.04%
17,245 $1.85 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $110,394 - $129,566
1,285 Added 7.87%
17,604 $1.54 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $332,292 - $444,657
4,529 Added 38.41%
16,319 $1.6 Million
Q1 2020

Apr 27, 2020

BUY
$64.5 - $97.79 $220,332 - $334,050
3,416 Added 40.79%
11,790 $901,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $32,314 - $40,432
448 Added 5.65%
8,374 $741,000
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $121,614 - $146,215
-1,931 Reduced 19.59%
7,926 $605,000
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $85,081 - $108,754
-1,295 Reduced 11.61%
9,857 $715,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $16,739 - $19,701
217 Added 1.98%
11,152 $900,000
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $851,289 - $1.05 Million
10,935 New
10,935 $1.01 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.